CorMedix Inc. — Director's Dealing 2010

Apr 1, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2010-03-30

Reporting Person: Houghton John C. (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-03-30	Common Stock, $0.001 par value per share	P	2800	—	Acquired	16328	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-03-30	Stock option (right to buy)	$3.1250	A	816231	Acquired	2020-03-30	Common Stock, $0.001 par value per share (816231)	Direct
2010-03-30	Warrants issued as a part of Units	$3.4375	P	1400	Acquired	2015-03-24	Common Stock, $0.001 par value per share (1400)	Direct

Footnotes

F1: These securities were issued as a part of 1,400 Units purchased by Mr. Houghton directly from the underwriters in the Company's initial public offering, which closed on March 30, 2010. The Units were purchased at $6.50 per Unit, the initial public offering price. Each Unit consists of two shares of common stock and a warrant to purchase one share of common stock.

F2: These options vest as follows: 1/3 on March 30, 2011; an additional 1/3 on March 30, 2012; and the remaining 1/3 on March 30, 2013.

F3: These warrants will become exercisable upon the earlier to occur of the expiration of the underwriters' over allotment option with respect to the Company's initial public offering, or the exercise in full of such over allotment option.